Status:
UNKNOWN
Afferent Neurocardiac Signals, Cue Reactivity, and Cognitive Control
Lead Sponsor:
Rutgers, The State University of New Jersey
Conditions:
Binge Drinking
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
Conscious attempts to regulate alcohol use are often undermined by automatic attention and arousal processes activated by alcohol cues, as well as by diminished ability to inhibit in-the-moment behavi...
Eligibility Criteria
Inclusion
- Must report at least 2 binge drinking episodes in the past month
- Have normal or corrected-to-normal vision
Exclusion
- History or presence of serious psychiatric disorders, neurological disorders, or head injury resulting in a loss of consciousness
- Presence of any serious medical condition
- Report of more than a few occasions (3-4) of illicit drug use, except for cannabis, in the preceding year
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05369169
Start Date
July 1 2022
End Date
April 30 2023
Last Update
July 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers, The State University of New Jersey
New Brunswick, New Jersey, United States, 08901